| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/05/1992 | US5110595 Implant preparations containing bioactive macromolecule for sustained delivery |
| 05/05/1992 | US5110593 Topical application of ointment of petrolatum, lanolin and oxyquinoline in carrier |
| 05/05/1992 | CA1300130C Derivatives of_ -cyclodextrin |
| 05/05/1992 | CA1300015C Compositions comprising 1-substituted azacycloalkanes |
| 05/05/1992 | CA1300009C Lhrh analog formulations |
| 05/05/1992 | CA1300008C Acid lyophilised pharmaceutical formulation of tissue plasminogen activator |
| 05/03/1992 | CA2488792A1 Antisense oligonucleotides for treatment of cancer |
| 05/02/1992 | CA2054830A1 Method for producing a new medicine for both treating and preventing peptic ulcer diseases and gastritis, and it's formulated medicines |
| 05/02/1992 | CA2054526A1 Controlled release formulations |
| 05/01/1992 | WO1992007561A1 Antiphlogistic and analgesic gel preparation |
| 05/01/1992 | CA2052246A1 Lithium treatment |
| 04/30/1992 | WO1992007590A1 Transdermal contraceptive formulations, methods and devices |
| 04/30/1992 | WO1992007064A1 Processing of yeast refuse and resulting product |
| 04/30/1992 | WO1992007006A1 A solid surface coated with a hydrophilic outer layer with covalently bonded biopolymers, a method of making such a surface, and a conjugate therefor |
| 04/30/1992 | WO1992006778A1 Use of fatty alcohol based compositions for preparing emulsions, method of preparing emulsions and emulsions so obtained |
| 04/30/1992 | WO1992006715A1 Mammalian model of a malignant disorder |
| 04/30/1992 | WO1992006714A1 Combination of hyaluronic acid with medicinal ingredient and production thereof |
| 04/30/1992 | WO1992006707A1 Methods and compositions for the treatment of cell proliferation disorders |
| 04/30/1992 | WO1992006702A1 A method for transplanting cells into the brain and therapeutic uses therefor |
| 04/30/1992 | WO1992006692A1 Composition for therapeutic, prophylactic or diagnostic use in connection with infections |
| 04/30/1992 | WO1992006680A1 Biphasic release formulations for lipophilic drugs |
| 04/30/1992 | WO1992006679A1 A method for drug formulation and a pharmaceutical composition |
| 04/30/1992 | WO1992006678A1 Biocompatible microcapsules |
| 04/30/1992 | WO1992006666A1 Dna gel stabilized thermal water liposomes |
| 04/30/1992 | DE4033928A1 Oel-in-wasser-emulsionen Oil-in-water emulsions- |
| 04/30/1992 | CA2091883A1 Transdermal contraceptive formulations, methods and devices |
| 04/30/1992 | CA2054302A1 Monoclonal antibody-containing agent |
| 04/29/1992 | EP0483105A1 Solid drug-delivery devices employing fatty acid esters or fatty alcohol ethers of alkanediols as percutaneous absorption enhancers |
| 04/29/1992 | EP0482948A1 A medicament composition containing 6-substituted alkoxy quinoxaline derivative and its production |
| 04/29/1992 | EP0482649A2 CM-chitin derivatives and use thereof |
| 04/29/1992 | EP0482580A1 Antidiarrheal compositions |
| 04/29/1992 | EP0482554A2 Transdermal Drug Delivery Preparation |
| 04/29/1992 | EP0482540A1 Novel derivatives of corticosteroids, process for their preparation and pharmaceutical composition containing them |
| 04/29/1992 | EP0482345A1 Nutritive composition and process for preparing the same |
| 04/29/1992 | EP0482213A1 Antineoplastic agent |
| 04/29/1992 | EP0482185A1 Cell internalizable conjugates and complexes including intracellularly cleavable moieties |
| 04/29/1992 | EP0482068A1 Cytokine and hormone carriers for conjugate vaccines |
| 04/29/1992 | EP0482018A1 Toxin uses |
| 04/29/1992 | CN1060610A Making method of high-content tea alkali control releasing agent |
| 04/28/1992 | US5108991 Useful for carrying therapeutical agents through skin and other body membranes |
| 04/28/1992 | US5108987 Transferrin or ceruloplasmin linked with arabinoside cytosine methotrexate, vincristin, daunomycin, 6-mercaptopurine and cyclophosphamide |
| 04/28/1992 | US5108921 Method for enhanced transmembrane transport of exogenous molecules |
| 04/28/1992 | US5108759 Endothelial envelopment drug carriers |
| 04/28/1992 | US5108758 Glassy amylose and a therapeutical or diagnostically active compound; for treating ulcerative colitis, crohm's desease and cancer of colon |
| 04/28/1992 | US5108757 Sustained release of nifedipine |
| 04/28/1992 | CA1299583C Effervescent couples, histamine h -antagonist effervescent compositions containing them and their preparation |
| 04/28/1992 | CA1299495C Pharmaceutical composition containing polypeptide |
| 04/27/1992 | WO1992007554A1 Implantable biodegradable material and method for producing same |
| 04/27/1992 | CA2052988A1 Nutritional composition and a process for its production |
| 04/25/1992 | WO1992007884A1 Organic polymer compound and production thereof |
| 04/25/1992 | CA2072072A1 Organic polymer compound and production thereof |
| 04/25/1992 | CA2054017A1 Antidiarrheal compositions |
| 04/23/1992 | CA2053462A1 Sticky composition for medical use |
| 04/22/1992 | EP0481732A1 Prolonged release preparation and polymers thereof |
| 04/22/1992 | EP0481725A1 Piroxicam containing cream |
| 04/22/1992 | EP0481701A1 Treatment composition |
| 04/22/1992 | EP0481526A1 Chelants |
| 04/22/1992 | EP0481240A2 Galactomannan derivate for the encapsulation or incorporation of drugs |
| 04/22/1992 | EP0481070A1 Multimeric gelsolin fusion constructs |
| 04/22/1992 | EP0481042A1 Amphoteric hydrogel for medical devices. |
| 04/22/1992 | EP0481007A1 Slow release vehicles for minimizing skin irritancy of topical compositions. |
| 04/22/1992 | EP0480996A1 Benzophenanthridine alkaloids for topical acne treatment |
| 04/22/1992 | EP0480986A1 6-(hydronaphtyl-1-ethyl)-4-hydroxy-3,4,5,6-tetrahydro-2h-pyran-2-ones and the corresponding hydroxy acids |
| 04/22/1992 | EP0480925A1 Fluorocarbon emulsions having saturated phospholipid emulsifiers. |
| 04/22/1992 | EP0290471B1 Flour, bread, milk, and other products from white sweet potatoes, cassava, edible aroids, amaranth, yams, and lotus |
| 04/22/1992 | CN1060408A Improved vaccine compositions |
| 04/21/1992 | US5106956 Anticarcinogenic agents |
| 04/21/1992 | US5106955 Process for preparation of antibody conjugates |
| 04/21/1992 | US5106951 Antineoplastic anthracyline agents intercalated with two aromatic side chains or an oligopeptide and covalently attached to an antibody |
| 04/21/1992 | US5106879 Applying triacontanol in ointment base |
| 04/21/1992 | US5106625 Transparent, extendible, adhesive, retentive |
| 04/21/1992 | US5106611 Use of modified diorganopolysiloxanes as antioxidants in cosmetics or in dermatology |
| 04/21/1992 | CA1299098C Alcohol-based antimicrobial compositions |
| 04/20/1992 | CA2053721A1 Antiphlogistic analgesic cream composition |
| 04/19/1992 | CA2053569A1 Galactomannan derivatives for coating or embedding medicinally active susbstances |
| 04/18/1992 | WO1992006703A1 Synthetic lung surfactant |
| 04/16/1992 | WO1992006120A1 Antigen-antibody conjugates |
| 04/16/1992 | WO1992005802A1 Polymeric carriers for release of covalently linked agents |
| 04/16/1992 | WO1992005801A1 Primate erythrocyte bound monoclonal antibody heteropolymers |
| 04/16/1992 | WO1992005797A1 Chemico-inmunological antineoplastic preparation |
| 04/16/1992 | WO1992005793A1 Targeted immunostimulation with bispecific reagents |
| 04/16/1992 | WO1992005781A1 Composition containing ephedrine base and alkyl salicylate for the delivery of ephedrine base in vapor form |
| 04/16/1992 | WO1992005778A1 Ionically cross-linked polymeric microcapsules |
| 04/16/1992 | WO1992005770A1 Drug delivery vehicles suspended in nonaqueous perfluorinated carrier |
| 04/16/1992 | WO1992005749A1 Soluble thrombogenesis inhibitor conjugates |
| 04/15/1992 | EP0480729A1 Microencapsulation for controlled oral drug delivery system |
| 04/15/1992 | EP0480640A1 Lactoneotrehalose, and its preparation and uses |
| 04/15/1992 | EP0480391A2 Emulsion-free emulsion polymers in sustained-release pharmaceutical compositions and their production |
| 04/15/1992 | EP0480305A1 Liquid nutritional products containing iota-carrageenan |
| 04/15/1992 | EP0480054A1 Percutaneously absorbable composition of morphine hydrochloride |
| 04/15/1992 | EP0479781A1 Pharmaceutical composition containing a hydrophilic active compound treated by an organic acid and encapsulated in a liposome. |
| 04/15/1992 | EP0453498A4 Method of promoting hair growth by applying a blood platelet extract |
| 04/15/1992 | EP0247114B1 Lipid containing plastics |
| 04/15/1992 | CN1060294A Improved oligosaccharide conjugate vaccines |
| 04/15/1992 | CN1060287A Process for preparing nitrogen heterocyclic ring alkane hydrocarbon derivatives |
| 04/15/1992 | CN1060216A Compositions and methods for administering therapeutically active compounds |
| 04/14/1992 | US5104976 Ribosome-inactivating glycoproteins, modified by oxidation of their osidic units and formation of a schiff's base and in-vivo prolonged action immunotoxins containing such a glycoprotein |
| 04/14/1992 | US5104896 Carboplatin composition |
| 04/14/1992 | US5104662 Intestinal mucous; gelation; lactic acid bacteria |
| 04/14/1992 | US5104656 Percutaneous treatment with a high potency non-steroidal anti-inflammatory agent |